Edgewise Therapeutics, Inc.
EWTX
$13.58
-$1.94-12.50%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
4/3/2025
-
MarketBeat
4/3/2025
-
GuruFocus
4/3/2025
-
Seeking Alpha - Healthcare
4/3/2025
-
Ticker Report
4/3/2025
-
TipRanks Financial Blog
4/2/2025
-
Seeking Alpha - Long Ideas
4/2/2025
-
SeekingAlpha
4/2/2025
-
Stock Options Channel
4/2/2025
-
GuruFocus
4/2/2025
-
Investopedia Headlines
4/2/2025
-
TipRanks Financial Blog
4/2/2025
-
The Fly
4/2/2025
-
The Fly
4/2/2025
-
Investor's Business Daily
4/2/2025
-
The Fly
4/2/2025
-
Tickeron - Stocks
4/2/2025
-
GuruFocus
4/2/2025
-
GuruFocus
4/2/2025
-
Zero Hedge
4/2/2025
-
GuruFocus
4/2/2025
-
GuruFocus
4/2/2025
-
GuruFocus
4/2/2025
-
GuruFocus
4/2/2025
-
PR Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 3, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
720-262-7002
Address
1715 38th Street
Boulder, CO 80301
Boulder, CO 80301
Country
Year Founded
Business Description
Sector
Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally...
more
